This is a linkpost for /r/discussion/lw/nzi/80_of_data_in_chinese_clinical_trials_have_been/
They are declare >80% of "1,622 clinical trials for new pharmaceutical drugs currently awaiting approval" to be bad. That doesn't mean that they take existing drugs off the market.
One problem is that consumers might decide >80% of all previously approved drugs are bad, but they don't know which, so they can't trust any of them. Chinese pharma revenues will drop as everyone who can will use drugs imported from abroad. Gray markets providing bulk medicine imports will flourish, but the buyers who can afford to use them should beware of fraudulent merchandise and of plain misunderstandings and mistranslations.
One problem is that consumers might decide >80% of all previously approved drugs are bad, but they don't know which, so they can't trust any of them.
It likely wasn't an easy decision. At the same time I don't think there was trust in the trials to begin with that they could destroy.
Chinese pharma revenues will drop as everyone who can will use drugs imported from abroad.
There are approved drugs from Western companies that can be legally brought in China. I think this Crackdown focuses more on Chinese companies.
Googling brought me to an article:...